Pharmaceutical Benefits Division (PBD) – Departmental Records Listing (July 2016 - December 2016)

Page last updated: 10 March 2017

PDF version: Pharmaceutical Benefits Division (PBD) – Departmental Records Listing (July 2016 - December 2016) (PDF 85 KB)

Record Number
Title
2016/002860 ABORIGINAL & TORRES STRAIT ISLANDER HEALTH - Policy - Section 100 Remote Area Aboriginal Health Services Program Handling Fee 2016
E16-13856 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Efficient Funding of Chemotherapy - Legislative Instrument Amendments 2017
E16-10187 PHARMACEUTICAL BENEFITS & ACCESS - Advice - Future directions for payment system for Community Pharmacy Programs
E16-5344 PHARMACEUTICAL BENEFITS & ACCESS - Advice - NPS therapeutic topics - Type 2 Diabetes Mellitus (T2DM) - Ongoing
E16-13508 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - 2016 - NDSS - Indigenous & rural & remote access arrangements
E16-6445 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Diabetes Product Section - Key stakeholder management  - 2016-2020
E16-4974 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - NDSS - 2016-2020 - Access Point Agreements
E16-5558 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - NDSS Agreement 2016-2020 - Introduction opening clauses to Agreement - Deliverables received
E16-5387 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - NDSS Agreement 2016-2020 - Schedule 16 - Transition
E16-5283 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - NDSS Agreement 2016-2020 - Schedule 3 - Assets & materials
E16-5286 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - NDSS Agreement 2016-2020 - Schedule 5 - Agents
2016/002406 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Pharmaceutical reform agreements - State & Territory liaison - Issues 2015-2016 & 2016-2017
2016/002550 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Pharmaceutical Reform Agreements - State & Territory liaison - Issues 2016-2017
E16-5102 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Sixth Community Pharmacy Agreement (6CPA) - 2016 Community Service Obligation (CSO) Financial related issues
E16-10189 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Sixth Community Pharmacy Agreement (6CPA) - 2016 Community Services Obligation (CSO) - Administration Agency - RFT
E16-13828 PHARMACEUTICAL BENEFITS & ACCESS - Agreements - Sixth Community Pharmacy Agreement (6CPA) - Community Service Obligation (CSO) - Confidentiality agreement
E16-5561 PHARMACEUTICAL BENEFITS & ACCESS - Benefit negotiation - Price disclosure - Low volume low discount - PBAC special meeting 2016 August
E16-4942 PHARMACEUTICAL BENEFITS & ACCESS - Committees - ANAO - Audit of the Fifth Community Pharmacy Agreement - Joint Committee of Public Accounts & Audit - August 2015
2016/002006 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Australian Community Pharmacy Authority - Independent Surveys undertaken - 2014-2015
2016/002007 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Australian Community Pharmacy Authority - Independent Surveys undertaken - 2016-2017
E16-9970 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Australian Community Pharmacy Authority (ACPA) - 2017
2016/002003 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Australian Community Pharmacy Authority (ACPA) - Member travel & accommodation 2014-2015
2016/002004 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Australian Community Pharmacy Authority (ACPA) - Member travel & accommodation 2015-2016
2016/002005 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Australian Community Pharmacy Authority (ACPA) - Member travel & accommodation 2016-2017
E16-11765 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Drug Utilisation Sub Committee (DUSC) - Meeting agenda - September 2016
E16-6360 PHARMACEUTICAL BENEFITS & ACCESS - Committees - Gaucher Committee - Meeting minutes - 2009
E16-5352 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - xxxx - Contract for services
E16-5158 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Preliminary research on Biological Disease Modifying Antirheumatic Drugs (bDMARDs)
E16-9277 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Probity & project support for the ongoing implementation of the Sixth Community Pharmacy Agreement
E16-5405 PHARMACEUTICAL BENEFITS & ACCESS - Contracting out - Research report into testoterone
E16-11485 PHARMACEUTICAL BENEFITS & ACCESS - Data collecting - NDSS - 2016-2020 - Senate estimates
E16-6443 PHARMACEUTICAL BENEFITS & ACCESS - Eligibility - Diabetes Product Section - special access to Insulin Pump Consumables and registration with 'other diabetes' 2016-2020
E16-6354 PHARMACEUTICAL BENEFITS & ACCESS - Eligibility - Life Saving Drugs Program - Treatment for gaucher disease - Guidelines
E16-6382 PHARMACEUTICAL BENEFITS & ACCESS - Enquiries - 2016-2020 - NDSS - Correspondence
E16-10332 PHARMACEUTICAL BENEFITS & ACCESS - Enquiries - Response to the Joint Committee of Public Accounts & Audit (JCPAA)
E16-13716 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Highly Specialised Drugs Program (HSD) - 2017 - Legislation
E16-5358 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - National Residential Medication Charts Documents
E16-5293 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - NDSS Agreement 2016-2020 - Schedule 10 - Information Technology
E16-5288 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - NDSS Agreement 2016-2020 - Schedule 6 - Administrative services
E16-5290 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - NDSS Agreement 2016-2020 - Schedule 7 - Universal services
E16-5291 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - NDSS Agreement 2016-2020 - Schedule 8 - Continuing Support Programs (CSPs)
E16-5292 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - NDSS Agreement 2016-2020 - Schedule 9 - New Support Programs (NSPs)
E16-9901 PHARMACEUTICAL BENEFITS & ACCESS - Implementation - Reporting - Pharmaceutical Benefits Division (PBD) - Project closure reports
  PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - 2014 10 - October Pt2
E16-15182 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - April 2012
E16-15326 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - August 2012
E16-12814 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - February 2012
E16-12797 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - January 2012
E16-15272 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - July 2012
E16-15245 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - June 2012
E16-12908 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - March 2012
E16-15222 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - May 2012
E16-15538 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications & program administration related emails - September 2012
E16-8806 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications and program administration related emails - 2014 11 - November Pt2
E16-6407 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications and program administration related emails - 2014 12 - December Pt2
E16-4939 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications and program administration related emails - 2015 Q1 - January to March - Part 1
E16-4953 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications and program administration related emails - 2015 Q1 - January to March - Part 2
E16-5307 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications and program administration related emails - 2015 Q1 - January to March - Part 3
E16-5431 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications and program administration related emails - 2015 Q1 - January to March - Part 4
E16-4938 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Growth Hormone Program - Patient applications and program administration related emails - 2015 Q2 - April to June - Part 5
E16-12949 PHARMACEUTICAL BENEFITS & ACCESS - Liaison - Medicare & Aged Care Payments Division regarding Sixth Community Pharmacy Agreement
E16-13184 PHARMACEUTICAL BENEFITS & ACCESS - Marketing - National Epidermolysis Bullosa Scheme - Educational materials
E16-5382 PHARMACEUTICAL BENEFITS & ACCESS - Meetings - NDSS Agreement 2016-2020 - Schedule 11 - Meetings & governance
E16-5502 PHARMACEUTICAL BENEFITS & ACCESS - Meetings - November 2016 - PBAC - Minor submissions
E16-15531 PHARMACEUTICAL BENEFITS & ACCESS - Meetings - Pharmaceutical Benefits Division (PBD) - Portfolio Board meeting 2017
E16-6738 PHARMACEUTICAL BENEFITS & ACCESS - Planning - Administration - National Epidermolysis Bullosa Scheme - 2016
E16-6357 PHARMACEUTICAL BENEFITS & ACCESS - Policy - Access & equity - New policy proposal - 2009-2010 - Budget - Addition of zavesca miglustat to the Life Saving Drugs Program
E16-8948 PHARMACEUTICAL BENEFITS & ACCESS - Policy - Growth Hormone Program - Pharmaceutical Benefits Scheme (PBS) Hospital Medication Chart (HMC) - Growth hormone prescribing
2016/002588 PHARMACEUTICAL BENEFITS & ACCESS - Policy - Insulin pump consumables other diabetes access policy - Pt3
E16-10619 PHARMACEUTICAL BENEFITS & ACCESS - Policy - IVF Program - Outstanding IVF Payments under old arrangements
E16-9523 PHARMACEUTICAL BENEFITS & ACCESS - Policy - IVF Program - Pricing
E16-6361 PHARMACEUTICAL BENEFITS & ACCESS - Policy - Life Saving Drugs Programme historical documents since 1995
E16-8827 PHARMACEUTICAL BENEFITS & ACCESS - Policy - Pharmacy Trial Program - Third tranche planning
E16-10150 PHARMACEUTICAL BENEFITS & ACCESS - Policy - Sixth Community Pharmacy Agreement Programs - Future options
E16-5399 PHARMACEUTICAL BENEFITS & ACCESS - Procedures - NDSS Agreement 2016-2020 - NDSS process & Standard Operating Procedures (SOPs)
E16-5388 PHARMACEUTICAL BENEFITS & ACCESS - Procedures - NDSS Agreement 2016-2020 - Schedule 17 - Guidelines & standards
E16-6065 PHARMACEUTICAL BENEFITS & ACCESS - Procedures - Remuneration - Standard operating procedures
E16-9068 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - NDSS agreement - 2016-2020 - Schedule 14 - Key performance indicators
E16-5383 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - NDSS Agreement 2016-2020 - Schedule 12 - Annual plan & budget
E16-5384 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - NDSS Agreement 2016-2020 - Schedule 13 - Reporting
E16-5219 PHARMACEUTICAL BENEFITS & ACCESS - Reporting - Pharmaceutical Benefits Division (PBD) - Business Systems Board Meetings
E16-5217 PHARMACEUTICAL BENEFITS & ACCESS - Research - Consumer medicines use - Including Consumer Medicines Information (CMI)
E16-13229 PHARMACEUTICAL BENEFITS & ACCESS - Research - Drug Utilisation Section - Antipsychotics 2016
E16-6667 PHARMACEUTICAL BENEFITS & ACCESS - Reviewing - NDSS - Finances Working Group
E16-5386 PHARMACEUTICAL BENEFITS & ACCESS - Reviewing - NDSS Agreement 2016-2020 - Schedule 15 - Scheme reviews
E16-9044 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - NDSS - 2016-2020 - Financial management
E16-5390 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - NDSS Agreement 2016-2020 - NDSS product schedule & suppliers
E16-13736 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - Section 100 legislative instrument - Data report change requests
E16-5249 PHARMACEUTICAL BENEFITS & ACCESS - Schedule management - Sixth Community Pharmacy Agreement (6CPA) - Community Service Obligation (CSO) - Funding pool - Administer & monitor funds
2016/001989 PUBLIC HEALTH & MEDICAL RESEARCH - Meetings - Alcohol Working Committee - Administration - 20 July 2016 - NHRMCROGEAG
2016/002184 PUBLIC HEALTH & MEDICAL RESEARCH - Meetings - Health Translation Advisory Committee (HTAC) - Agenda papers & records - 14 Sep 2016 - NHMRCROGEAG